Receive detailed cost breakdown within 24-48 hours with no obligation to book
Reads were trimmed to remove adapter sequences and aligned to the human reference genome
These results, nonetheless, have generated interest in this peptide across all biological domains
10.1136/gutjnl-2016-312574 Summary Keywords proton pump inhibitors, digestive diseases, microbiota, intestinal flora, Clostridium difficile , inflammatory bowel disease, short-chain fatty acids Citation Tian L, Huang C, Fu W, Gao L, Mi N, Bai M, Ma H, Zhang C, Lu Y, Zhao J, Zhang X, Jiang N, Lin Y, Yue P, Yuan J and Meng W (2023) Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota
Its natural occurrence in the body also means established metabolic pathways for processing and elimination